BRIM Biotechnology, Inc. (TPE:6885)
Taiwan
· Delayed Price · Currency is TWD 23.00
+0.05 (0.22%)
At close: Apr 29, 2026
BRIM Biotechnology Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Revenue | 5.49 | 0.33 | 0.09 | 0.53 | 0.36 | Upgrade
|
| Revenue Growth (YoY) | 1548.65% | 270.00% | -82.89% | 46.11% | -99.60% | Upgrade
|
| Cost of Revenue | 4.24 | 0.31 | - | - | - | Upgrade
|
| Gross Profit | 1.25 | 0.02 | 0.09 | 0.53 | 0.36 | Upgrade
|
| Selling, General & Admin | 123.68 | 106.31 | 112.33 | 72.96 | 44.97 | Upgrade
|
| Research & Development | 330.54 | 238.5 | 581.88 | 145.89 | 48.6 | Upgrade
|
| Operating Expenses | 454.22 | 344.81 | 694.22 | 218.85 | 93.58 | Upgrade
|
| Operating Income | -452.97 | -344.79 | -694.13 | -218.33 | -93.22 | Upgrade
|
| Interest Expense | -0.5 | -0.09 | -0.15 | -0.08 | -0.11 | Upgrade
|
| Interest & Investment Income | 31.76 | 32.9 | 21.8 | 0.83 | 0.5 | Upgrade
|
| Earnings From Equity Investments | -13.47 | -27.03 | -24.59 | -62.62 | -47.94 | Upgrade
|
| Currency Exchange Gain (Loss) | -15.66 | 23.53 | 9.03 | 5.9 | -1.76 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.07 | - | 0 | 0.02 | 4.21 | Upgrade
|
| EBT Excluding Unusual Items | -450.92 | -315.47 | -688.04 | -274.28 | -138.32 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.01 | - | 32.87 | Upgrade
|
| Other Unusual Items | 0.01 | - | - | - | - | Upgrade
|
| Pretax Income | -450.91 | -315.47 | -688.02 | -274.28 | -105.45 | Upgrade
|
| Earnings From Continuing Operations | -450.91 | -315.47 | -688.02 | -274.28 | -105.45 | Upgrade
|
| Minority Interest in Earnings | 14.46 | - | - | - | - | Upgrade
|
| Net Income | -436.45 | -315.47 | -688.02 | -274.28 | -105.45 | Upgrade
|
| Net Income to Common | -436.45 | -315.47 | -688.02 | -274.28 | -105.45 | Upgrade
|
| Shares Outstanding (Basic) | 132 | 117 | 101 | 71 | 59 | Upgrade
|
| Shares Outstanding (Diluted) | 132 | 117 | 101 | 71 | 59 | Upgrade
|
| Shares Change (YoY) | 12.74% | 16.02% | 41.02% | 20.23% | 0.72% | Upgrade
|
| EPS (Basic) | -3.32 | -2.70 | -6.84 | -3.85 | -1.78 | Upgrade
|
| EPS (Diluted) | -3.32 | -2.70 | -6.84 | -3.85 | -1.78 | Upgrade
|
| Free Cash Flow | -329.97 | -282.14 | -599.15 | -172.98 | -113.35 | Upgrade
|
| Free Cash Flow Per Share | -2.51 | -2.42 | -5.96 | -2.43 | -1.91 | Upgrade
|
| Gross Margin | 22.77% | 6.61% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -8250.89% | -103539.04% | -771250.00% | -41506.84% | -25893.06% | Upgrade
|
| Profit Margin | -7949.94% | -94735.74% | -764468.89% | -52143.92% | -29291.39% | Upgrade
|
| Free Cash Flow Margin | -6010.38% | -84726.73% | -665723.33% | -32885.74% | -31485.83% | Upgrade
|
| EBITDA | -417.6 | -340.5 | -693.12 | -218.02 | -93.01 | Upgrade
|
| D&A For EBITDA | 35.37 | 4.29 | 1.01 | 0.31 | 0.2 | Upgrade
|
| EBIT | -452.97 | -344.79 | -694.13 | -218.33 | -93.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.